STroke imAging pRevention and Treatment-Extending the time for Thrombolysis in Emergency Neurological Deficits "START-EXTEND"

Recruiting

Phase N/A Results N/A

Summary of Purpose

To test the hypothesis that ischaemic stroke patients selected with significant penumbral mismatch at 3 - 9 hours post onset of stroke will have improved clinical outcomes when given intravenous tPA compared to placebo.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 July 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Stroke Research Institute (NSRI)

Trial Design

The study will be a randomised, multicentre, double blinded, placebo controlled phase 3 trial (2 arm with 1:1 randomisation) within a larger cohort study of ischaemic stroke patients. Patients randomised to treatment will be stratified for time of randomisation after stroke to within <6 hours and 6-9 hours.

Contacts

  • Amanda Gibbins Research Assistant Neuroscience Trials Australia Level 1, Neuroscience Building Heidelberg Repatriation Hospital 300 Waterdale Road Heidelberg Heights, Vic 3081 Australia

    agibbins@neurotrialsaustralia.com